EH
Esther Hong Loop Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
NEUP
1
Neuphoria Therapeutics Inc. Common Stock
NEUP
$24.4M
| $12.99 | $17 |
31%
upside
| Buy |
9 Mar ‘23
2 years ago |
|
2
ATAI Life Sciences
ATAI
$969M
| $4.52 | $18 |
298%
upside
| Buy |
1 Nov ‘22
2 years ago |
|
3
Acadia Pharmaceuticals
ACAD
$4.28B
| $25.39 | $17 |
33%
downside
| Hold |
1 Nov ‘22
2 years ago |
|
|
CMPS
4
Compass Pathways
CMPS
$478M
| $4.98 | $34 |
583%
upside
| Buy |
1 Nov ‘22
2 years ago |
|
5
Axsome Therapeutics
AXSM
$6.45B
| $129.29 | $95 |
27%
downside
| Buy |
1 Nov ‘22
2 years ago |
|
6
Spero Therapeutics
SPRO
$113M
| $2 | $2 |
0%
upside
| Hold |
20 May ‘22
3 years ago |
|
7
Athira Pharma
ATHA
$15.2M
| $0.3850 | $33 |
8,471%
upside
| Buy |
21 Apr ‘22
3 years ago |
|
|
NEUP
8
Neuphoria Therapeutics Inc. Common Stock
NEUP
$24.4M
| $12.99 | $21 |
62%
upside
| Buy |
10 Jan ‘22
3 years ago |
|
|
9
ATAI Life Sciences
ATAI
$969M
| $4.52 | $35 |
674%
upside
| Buy |
13 Jul ‘21
4 years ago |
|
|
10
Axsome Therapeutics
AXSM
$6.45B
| $129.29 | $112 |
13%
downside
| Buy |
10 Jun ‘21
4 years ago |
|
|
11
Acadia Pharmaceuticals
ACAD
$4.28B
| $25.39 | $29 |
14%
upside
| Hold |
10 Jun ‘21
4 years ago |
|
12
Aldeyra Therapeutics
ALDX
$342M
| $5.70 | $32 |
461%
upside
| Buy |
16 Dec ‘20
4 years ago |
|